As a leading provider of solutions for protein characterisation, Malvern Instruments is taking an active role at the CHI's 10th Annual PepTalk event in San Diego in January (11-14 Jan 2011).
Croatian pharmaceutical company Belupo recently submitted first eCTDs to Croatian regulatory authority, HALMED. Agency for Medicinal Products and Medical Devices of Croatia in June 2010 issued national eCTD specification in which Module 1 is somewhat different than in EU.
Lonza and Stason Pharmaceuticals, Inc. announced today that they signed an agreement granting Stason a world-wide non-exclusive license to use Lonza's GS (glutamine synthetase) Gene Expression System™.
Please enjoy the December issue of DASGIP Spotlight highlighting three of our latest news on products, applications and business development.
Brand new horizontal paddle vacuum dryer, designed and patented by ITALVACUUM.
CRIOX System, an international Italvacuum patent that counts more than 400 units operating in more than 30 countries, consists of a rotary vacuum dryer/powderer capable to total extract all types of solvents from the wet powders coming from filtering or centrifuge.
Eco-compatible dimensions and incomparable performance for a completely safe product.
This year's Drug Delivery to the Lungs conference (DDL21; 8-10 Dec 10; Edinburgh, Scotland), was a resounding success for Malvern Instruments with Deborah Huck, Malvern's product technical specialist for imaging, and co-authors scooping the industry poster award for, "Characterising a Nasal Spray Formulation from Droplet to API Particle Size." The prize was presented to the team by Jolyon Mitchell of Trudell Medical International and highlights Malvern's active development of analytical instrumentation for inhaled product applications.
The right solution for small size production.
Perfect fit with Shimadzu's LabSolutions software / for most chromatographic applications in the lab.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.